Single-cell analyses of global cohorts outline determinants of immune aging and link the ratio of GZMK+ to GZMB+ Tem cells to health trajectories
Immunity, 2026
Terekhova M., Kleverov M., Francis T., Usoltsev D., Bohacova P., Arthur L., Tsurinov P., Kleverov D., Trinity L., Husarcikova K., Molotkov I., Grabauskas T., Fathi A., Milbourn E., Newton E., Siegel L., Ghanchi A., Tse U., Pollock R., Duggal N., Lord J., Lazarus N., Ellebedy A., Ucar D., Harridge S., Artomov M., Artyomov M.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Immunological & Inflammatory Diseases Aging | Pathophysiology | Plasma | Olink Explore 3072/384 Olink Explore HT |
Abstract
Human immune aging is heterogeneous, with immune responses becoming increasingly variable over the lifespan. Here, we integrated seven large-scale public single-cell peripheral blood mononuclear cell (PBMC) datasets and a newly generated cohort, encompassing 2,609 ostensibly healthy individuals across diverse ages, ancestries, and biological sexes. We identified both conserved and cohort-associated age-associated remodeling across 59 immune populations, together with sex- and ancestry-dependent immune differences. CD8+ T cells emerged as major drivers of aging heterogeneity, with the GZMK+/GZMB+ effector memory ratio distinguishing healthy and pathology-associated aging trajectories. This ratio reflected immune remodeling driven by chronic viral exposure, including CMV, and disease-associated immune dysregulation, with the dominant driver varying across populations. Proteomic profiling across four cohorts revealed a Tem GZMB+ plasma signature associated with inflammaging, poor self-reported health, all-cause mortality, and increased risk of immune-related, metabolic, and cardiovascular diseases. Together, these findings define clinically relevant immune determinants for monitoring and guiding healthy aging interventions.